Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases

Peter J O’Brien1 Eli Lilly and Company Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA

Rajeev Ramanathan2 Esoterix Coagulation, Aurora, CO, USA

Jonathan M Yingling1 Eli Lilly and Company Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA

Jose Baselga3 Vall d’Hebron University Hospital, Barcelona, Spain

Mace L Rothenberg4 Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA

Michael Carducci5 The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA

Thomas Daly1 Eli Lilly and Company Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA

Dorothy Adcock2 Esoterix Coagulation, Aurora, CO, USA

Michael Lahn1 Eli Lilly and Company Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USACorrespondence[email protected]

Your download is now in progress and you may close this window